Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Post-prandial glucose response (PPGR) is a physiological measurement of the blood glucose excursion that occurs in the 2 to 4 hours following food ingestion. It represents a complex interplay of gastric emptying, intestinal absorption, insulin and glucagon secretion, and peripheral glucose disposal (Scientific Reports, 2020). In healthy individuals, these levels are tightly regulated; however, in type 2 diabetes, the response is often characterized by significant hyperglycemia due to impaired early-phase insulin release and insulin resistance (Diabetes Spectrum, 2016). Persistent postprandial hyperglycemia is recognized as an independent risk factor for cardiovascular disease and is a major contributor to elevated HbA1c levels, even in patients with well-controlled fasting glucose (Dove Medical Press, 2024). Therapeutic strategies targeting PPGR include lifestyle modifications and pharmacological agents such as rapid-acting insulin analogs, meglitinides, and alpha-glucosidase inhibitors, which work to flatten glucose spikes and reduce oxidative stress (Med Ed 101, 2020). Efficient management of this response is crucial for preventing long-term diabetic complications and achieving overall metabolic stability.
Management of this response involves diverse mechanisms including the stimulation of early-phase insulin secretion (meglitinides, rapid-acting insulin), suppression of glucagon release and slowing of gastric emptying (GLP-1 receptor agonists), and the inhibition of intestinal alpha-glucosidase to delay carbohydrate absorption (acarbose).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Post-prandial glucose response (PPGR).